South Africa is home to one of the world's worst HIV/AIDS epidemics. At least 8.5 million people here are living with HIV - ...

In this month’s issue, the Sexpert advises readers on how to navigate discussions of PrEP and sexual health while in the ...

Investors' focus will likely be on GILD's HIV franchise performance and oncology sales when the company reports ...

The FDA said that PrEP – used to protect at-risk people such as an HIV-negative individual with ... which suggests it is expecting high demand for the injectable alternative.

Take away safe spaces for key populations (KPs) and adolescent girls and young women (AGYW) and increase their vulnerability to HIV-related sigma and discrimination, gender-based violence, mental ...

The mpox paper had undergone months of peer review at a scientific journal as well as extensive internal review at the CDC.

Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

Scientists are struggling to respond to a Trump administration order to review papers already submitted for publication for ...

Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 EPS, expectations were $1.85. Operator: Thank you for standing by. Welcome to ...

Q1 2025 Earnings Conference Call February 5, 2025 4:30 PM ETCompany ParticipantsMike Watts - Corporate Vice President, ...